GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker ...
Tag: biotech
Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central nervous ...
Big Pharma’s bet on China biotech is a rare trade bright spot
AT A time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical dealmaking has become a rare ...
After TikTok, China biotech next to face wrath of US congress
CHINA hawks in the US House are working to overcome a last-ditch lobbying effort and pass legislation as early as ...
US House passes bill to blacklist some China biotech firms
CHINA hawks in the US House overcame a last-ditch lobbying effort and passed legislation on Monday (Sep 9) night that ...
US House passes bill to blacklist some China biotech firms
CHINA hawks in the US House overcame a last-ditch lobbying effort and passed legislation on Monday (Sep 9) night that ...
Temasek-backed biotech Oxford Nanopore wants to make genetics tech accessible to startups
The London-listed company is working with Singapore to catalogue 10,000 genes, which can help to pinpoint how genetic factors influence ...
Hilleman-Bharat Biotech partnership brings new oral cholera vaccine to market
Hillchol utilises a single, genetically engineered inactivated strain that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech have ...
China’s Fosun to buy out Henlius Biotech, values it at HK$13.37 billion
CHINESE conglomerate Fosun International will buy the remaining stake in Shanghai Henlius Biotech that it does not already own in ...
Biotech firm Valneva guides for nearly double product sales by 2026
FRANCE’S Valneva on Wednesday (Mar 20) said it expects to nearly double its annual product sales by 2026, and edged ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.